Best telehealth for Mounjaro in 2026: how to choose

It depends on your goal and diagnosis. Mounjaro is FDA-approved for type 2 diabetes, not weight loss — the weight-loss version of the same tirzepatide molecule is Zepbound. A legitimate provider prescribes Mounjaro on-label for diabetes, or Zepbound if weight is your goal. Compare providers on total monthly cost, insurance and prior-authorization help, and ongoing support. The best provider is the one that routes you to the correct product.

Mounjaro is FDA-approved for type 2 diabetes, not weight loss, so for weight loss the on-label option is Zepbound (identical active drug, tirzepatide, in a weight-management product — and it also carries a sleep-apnea indication). Some clinicians prescribe Mounjaro off-label, but insurance almost never covers off-label weight-loss use, and Zepbound has its own self-pay pricing plus additional coverage routes. A good provider will point you to the right product.

Mounjaro's list price is about $1,069/mo. Cash-pay is lower through Lilly's self-pay program and the federal TrumpRx portal. If you have a diabetes diagnosis, insurance often covers Mounjaro with a prior authorization the provider can file — usually the cheapest path by a wide margin. Telehealth adds a visit or membership fee, so compare total monthly cost at your maintenance dose.

Five: (1) Given my diagnosis and goal, should I be on Mounjaro or Zepbound — and why? (2) What is my total monthly cost including membership, at my maintenance dose? (3) Do you bill insurance and file the diabetes prior authorization? (4) If Mounjaro is non-preferred on my plan, will you file a formulary exception? (5) Is there ongoing clinician access for dose changes and side effects? A provider who cannot answer the first question clearly is the wrong one.

Yes, through licensed clinicians. A legitimate program involves a real evaluation by a US-licensed provider who prescribes only if appropriate, dispensed by a pharmacy. Because Mounjaro is a diabetes drug, a good provider confirms you are getting the right medication for your goal — and avoids off-label weight-loss prescribing that insurance will not cover. Avoid any site selling Mounjaro without a prescription or clinician.

Some plans prefer a different diabetes GLP-1, putting Mounjaro on a higher tier or behind a step. That is a formulary problem, not a criteria problem — the right tool is a formulary exception, where your prescriber argues medical necessity (preferred alternatives failed, caused intolerance, or are contraindicated). Ask prospective providers whether they file formulary exceptions, not just standard prior authorizations. See our formulary-exception guide.

Avoid any service that: prescribes Mounjaro for weight loss without explaining it is off-label and that Zepbound is the on-label option; sells without a real clinician evaluation; advertises "compounded Mounjaro" (Mounjaro is branded — that phrasing is a misnomer); hides the total maintenance-dose cost; or locks you into prepaid commitments with no refund. Transparency about product, price, pharmacy, and clinician is the baseline.